1. Home
  2. ATHA vs CLIK Comparison

ATHA vs CLIK Comparison

Compare ATHA & CLIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATHA
  • CLIK
  • Stock Information
  • Founded
  • ATHA 2011
  • CLIK 2017
  • Country
  • ATHA United States
  • CLIK Hong Kong
  • Employees
  • ATHA N/A
  • CLIK N/A
  • Industry
  • ATHA Medicinal Chemicals and Botanical Products
  • CLIK
  • Sector
  • ATHA Health Care
  • CLIK
  • Exchange
  • ATHA Nasdaq
  • CLIK NYSE
  • Market Cap
  • ATHA 22.3M
  • CLIK 24.6M
  • IPO Year
  • ATHA 2020
  • CLIK 2024
  • Fundamental
  • Price
  • ATHA $0.54
  • CLIK $1.43
  • Analyst Decision
  • ATHA Buy
  • CLIK
  • Analyst Count
  • ATHA 4
  • CLIK 0
  • Target Price
  • ATHA $11.25
  • CLIK N/A
  • AVG Volume (30 Days)
  • ATHA 325.4K
  • CLIK 103.4K
  • Earning Date
  • ATHA 11-07-2024
  • CLIK 02-14-2025
  • Dividend Yield
  • ATHA N/A
  • CLIK N/A
  • EPS Growth
  • ATHA N/A
  • CLIK N/A
  • EPS
  • ATHA N/A
  • CLIK 0.06
  • Revenue
  • ATHA N/A
  • CLIK $5,657,132.00
  • Revenue This Year
  • ATHA N/A
  • CLIK N/A
  • Revenue Next Year
  • ATHA N/A
  • CLIK N/A
  • P/E Ratio
  • ATHA N/A
  • CLIK $22.85
  • Revenue Growth
  • ATHA N/A
  • CLIK 36.12
  • 52 Week Low
  • ATHA $0.41
  • CLIK $1.15
  • 52 Week High
  • ATHA $4.30
  • CLIK $4.39
  • Technical
  • Relative Strength Index (RSI)
  • ATHA 36.91
  • CLIK N/A
  • Support Level
  • ATHA $0.56
  • CLIK N/A
  • Resistance Level
  • ATHA $0.61
  • CLIK N/A
  • Average True Range (ATR)
  • ATHA 0.04
  • CLIK 0.00
  • MACD
  • ATHA -0.01
  • CLIK 0.00
  • Stochastic Oscillator
  • ATHA 8.45
  • CLIK 0.00

About ATHA Athira Pharma Inc.

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.

About CLIK CLICK HOLDINGS LIMITED

Click Holdings Ltd is a human resources solutions provider, specializing in offering comprehensive human resources solutions. It is focused on talent sourcing and the provision of temporary and permanent personnel to customers and also in placing professional accountants and company secretaries, registered nurses and healthcare workers as well as other blue-collar workers, for direct hire and contract staffing roles. The Company operates in three segments, 1) professional solution services, 2) nursing solution services and 3) logistic and other solution services. Maximum revenue is generated from Professional solution services and Hong Kong.

Share on Social Networks: